- Home
- INBX vs BCSF Comparison
INBX vs BCSF Comparison
Compare INBX & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBX | BCSF |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 799.8M |
| IPO Year | 2024 | 2015 |
Fundamental Metrics
Financial Performance| Metric | INBX | BCSF |
|---|---|---|
| Price | $133.53 | $13.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $150.00 | $14.00 |
| AVG Volume (30 Days) | ★ 486.3K | 345.2K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 14.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.03 |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $12.80 | $11.82 |
| 52 Week High | $155.29 | $16.00 |
Technical Indicators
Market Signals| Indicator | INBX | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 66.58 | 57.98 |
| Support Level | $69.30 | $13.47 |
| Resistance Level | $155.29 | $13.76 |
| Average True Range (ATR) | 13.75 | 0.31 |
| MACD | 0.62 | 0.02 |
| Stochastic Oscillator | 69.23 | 54.24 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.